Ciputra Development Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ciputra Development Tbk trades at Rp575 (market cap 10.38T, 4.65M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 24.2K 24h volume). The key difference: Ciputra Development Tbk is far larger — about 62× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Ciputra Development Tbk is more actively traded (4.65M versus 24.2K). Which is the better fit depends on your goals.
| CTRA | OBAT | |
|---|---|---|
Market Cap | 10.38T | 167.37B |
Volume | 4.65M | 24.2K |
Lot | 46.48K | 242 |
Turnover | 2.67B | 5.98M |
Average Price | 574.01 | 246.98 |
Value | 2.67B | 5.98M |
Indicative Equilibrium Price | 565 | 246 |
Indicative Equilibrium Volume | 819 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →